Correlation Between Ascletis Pharma and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascletis Pharma and Coya Therapeutics, Common, you can compare the effects of market volatilities on Ascletis Pharma and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Coya Therapeutics,.
Diversification Opportunities for Ascletis Pharma and Coya Therapeutics,
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ascletis and Coya is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Ascletis Pharma and Coya Therapeutics,
Assuming the 90 days horizon Ascletis Pharma is expected to generate 0.93 times more return on investment than Coya Therapeutics,. However, Ascletis Pharma is 1.08 times less risky than Coya Therapeutics,. It trades about -0.21 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.29 per unit of risk. If you would invest 21.00 in Ascletis Pharma on September 13, 2024 and sell it today you would lose (3.00) from holding Ascletis Pharma or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ascletis Pharma vs. Coya Therapeutics, Common
Performance |
| Timeline |
| Ascletis Pharma |
| Coya Therapeutics, Common |
Ascletis Pharma and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ascletis Pharma and Coya Therapeutics,
The main advantage of trading using opposite Ascletis Pharma and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| Ascletis Pharma vs. Sino Biopharmaceutical Ltd | Ascletis Pharma vs. Defence Therapeutics | Ascletis Pharma vs. Aileron Therapeutics | Ascletis Pharma vs. Enlivex Therapeutics |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |